LGVN
USDLongeveron Inc. Class A Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$1.339
Haut
$1.339
Bas
$1.260
Volume
0.31M
Fondamentaux de l'Entreprise
Capitalisation Boursière
19.2M
Industrie
Biotechnologie
Pays
United States
Statistiques de Trading
Volume Moyen
0.13M
Bourse
NCM
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
Longeveron® to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
MIAMI, June 09, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related
Longeveron® to Attend BIO International Convention 2025
Focus on potential partnership and strategic opportunities for the Company's stem cell therapy program for Alzheimer's diseaseRecent Type B meeting with FDA provided alignment on a planned single, pivotal Phase 2/3
Actions Connexes
AVD
American Vanguard Corporation ($0.10 Par Value)
WES
Western Midstream Partners LP Common Units Representing Limited Partner Interests
AREC
American Resources Corporation
BMEA
Biomea Fusion Inc.
AIZN
Assurant Inc. 5.25% Subordinated Notes due 2061
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.